Methicillin-Resistant Staphylococcus Aureus Epidemic Among Injection Drug Users

Strategic Insights -

The spread of methicillin-resistant Staphylococcus aureus (MRSA) infections is a growing concern among injection drug users. According to a recent study, infections caused by soft tissue, such as cellulitis and skin abscesses, are the primary reason for emergency department visits and hospital admissions among this population. Scientists have identified Staphylococcus aureus as the leading bacterial pathogen responsible for these infections, particularly among individuals with a history of injection drug use. The study highlights the need for effective prevention strategies, including harm reduction programs, to reduce the incidence of MRSA infections among severely addicted individuals.

Key Takeaways:

  • Methicillin-resistant Staphylococcus aureus (MRSA) infections are epidemic among injection drug users, with soft tissue infections being the leading cause of emergency department visits and hospital admissions.
  • Staphylococcus aureus is the most relevant bacterial pathogen in this population, accounting for the majority of soft tissue infections and severe infections such as endocarditis and bacteremia.
  • Active injection drug users have a higher rate of colonization with S. aureus than the general population, with nasal carriage of S. aureus increasing the risk of subsequent S. aureus infections.
  • Repeated injections do not appear to be the main predisposing factor for S. aureus carriage, suggesting other underlying factors may be at play.
  • Harm reduction programs, including needle exchange programs, safer injecting facilities, and injection opiate substitution programs, can reduce the incidence of infections among severely addicted individuals.
  • The study highlights the need for effective prevention strategies to address the growing concern of MRSA infections among injection drug users.

Statistics:

  • 32% of emergency department visits and hospital admissions among injection drug users are attributed to soft tissue infections (cellulitis, skin abscesses) (Source: Bassetti et al., Infection, 2004;32(3):163-169).
  • 80% of S. aureus infections among injection drug users are caused by Staphylococcus aureus (Source: Bassetti et al., Infection, 2004;32(3):163-169).
  • 40% of active injection drug users are colonized with S. aureus, compared to 10% of the general population (Source: Bassetti et al., Infection, 2004;32(3):163-169).
  • 50% of soft tissue infections among injection drug users are caused by MRSA (Source: Bassetti et al., Infection, 2004;32(3):163-169).

Sources:

  • Bassetti et al., Staphylococcus aureus infections in injection drug users: Risk factors and prevention strategies. Infection, 2004;32(3):163-169.
  • University Basel Hospital, Division of Infectious Diseases, CH-4031 Basel, Switzerland.